盐酸左氧氟沙星治疗慢性盆腔炎的疗效评估

目的：探讨盐酸左氧氟沙星治疗慢性盆腔炎的临床疗效。方法：选择2015年3月—2016年1月收治的慢性盆腔炎患者50例，分为观察组和对照组各25例。对照组给予替硝唑治疗，观察组给予替硝唑联合盐酸左氧氟沙星治疗。结果：观察组总有效率为100.00%（25/25），对照组为80.00%（20/25），组间差异有统计学意义（P＜0.05）。观察组不良反应发生率为20.00%（5/25），对照组为8.00%（2/25），组间差异无统计学意义（P＞0.05）。观察组复发率为4.00%（1/25），对照组为24.00%（6/25），组间差异有统计学意义（P＜0.05）。观察组血流动力学指标、免疫学指标均明显低于对照组（P＜0.05）。结论：盐酸左氧氟沙星治疗慢性盆腔炎效果较好，不良反应小，值得推广。

Evaluation of effect of levolfoxacin hydrochloride in the treatment of chronic pelvic inlfammatory disease

Objective:To investigate the clinical efficacy of levofloxacin hydrochloride in the treatment of chronic pelvic inlfammatory disease.Methods: From March 2015 to Jan. 2016, 50 cases of chronic pelvic inlfammatory disease were selected in the hospital and randomly divided into an observation group and a control group with 25 cases each. The control group was treated with tinidazole and the observation group was treated with tinidazole combined with levolfoxacin hydrochloride. Results: The total effective rate of the observation group was 100%(25/25) and the control group was 80%(20/25) and the difference between the groups was statistically signiifcant(P<0.05). The incidence of adverse reactions in the observation group was 20%(5/25) and the control group was 8%(2/25) and there was no signiifcant difference between the two groups(P>0.05). The recurrence rate of the observation group was 4%(1/25) and the control group was 24%(6/25), and the difference between the groups was statistically signiifcant(P<0.05). The hemodynamic indexes and immunological parameters were signiifcantly lower in the observation group than those in the control group(P<0.05).Conclusion:The effect of levolfoxacin hydrochloride in the treatment of chronic pelvic inlfammatory disease is better and the adverse reaction is small, which is worth promoting.